Sanjivani Paranteral earnings call announcements

Earnings CallSanjivani Paranteral Ltd SANJIVINAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sanjivani Paranteral Investor Presentation: Key Takeaways

Sanjivani Paranteral Q1 FY27 consolidated revenue grew 33.8% YoY to ₹238.4 Mn, driven by the new Pune IV-fluid plant ramp-up. Transitioning to a multi-vertical platform with injectables, orals, and nutraceuticals.

Call

Guides 110% growth

Earnings CallSanjivani Paranteral Ltd SANJIVIN

Sanjivani Paranteral Earnings Call: Key Takeaways

Sanjivani Paranteral Q4 FY26 earnings transcript. Management transitions to a multi-vertical platform with base formulation business and new IVF and nutraceutical ventures.

Earnings CallSanjivani Paranteral Ltd SANJIVIN

Sanjivani Paranteral Earnings Call: Key Takeaways

Sanjivani Paranteral's Q4 & FY26 presentation shows significant decline in standalone financials. Focus remains on injectables (53.5% FY26 revenue) and export markets (78.5% FY26 revenue).